Allegis Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Allegis Investment Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$235K	Sell	3,715 -556	-13%	-$35.8K	0.07%	187
2017 Q4	$262K	Sell	4,271 -4,111	-49%	-$257K	0.08%	188
2017 Q3	$534K	Buy	8,382 +1,046	+14%	+$61.1K	0.13%	148
2017 Q2	$409K	Buy	7,336 +1,505	+26%	+$81.9K	0.1%	176
2017 Q1	$317K	Sell	5,831 -243	-4%	-$13.3K	0.08%	195
2016 Q4	$355K	Sell	6,074 -1,697	-22%	-$92.8K	0.11%	165
2016 Q3	$419K	Sell	7,771 -860	-10%	-$55.2K	0.16%	146
2016 Q2	$630K	Buy	8,631 +531	+7%	+$37.5K	0.32%	99
2016 Q1	$517K	Buy	8,100 +216	+3%	+$13.6K	0.3%	109
2015 Q4	$542K	Buy	+7,884	New	+$521K	0.3%	94

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allegis Investment Advisors's BMY Position: Q1 2018 in Review

Allegis Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q1 2018, selling an estimated $35.8K and leaving 3,715 shares worth $235K. The position accounts for 0.07% of the portfolio, ranked #187.

Allegis Investment Advisors first reported a position in BMY in Q4 2015 and has held it in 10 quarters since. The position peaked at $630K in Q2 2016. 1,747 funds tracked by Wall St. Rank hold BMY as of Q1 2018.

Allegis Investment Advisors held 3,715 shares of Bristol-Myers Squibb worth $235K as of Q1 2018.
Allegis Investment Advisors sold 556 Bristol-Myers Squibb shares in Q1 2018, an estimated $35.8K.
Bristol-Myers Squibb made up 0.07% of Allegis Investment Advisors's portfolio in Q1 2018, its #187 holding.
Allegis Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 10 quarters since.
Allegis Investment Advisors's Bristol-Myers Squibb position peaked at $630K in Q2 2016.
1,747 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2018.

Based on Allegis Investment Advisors's 13F filing for Q1 2018, filed 24 Apr 2018.